<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7056717\results\search\disease\results.xml">
  <result pre="GP was produced by infecting HeLa cells with a recombinant" exact="vaccinia virus" post="that expresses the EBOV GP-histag protein, and the GP-histag"/>
  <result pre="2006). In early studies, it has also been shown that" exact="influenza" post="vaccines delivered by ID injection are safe and immunogenic"/>
  <result pre="vaccination against Tuberculosis. More recent studies showed that administration of" exact="influenza" post="vaccines through ID immunization required reduced vaccine doses for"/>
  <result pre="eliciting similar levels of immune responses as IM delivery of" exact="influenza" post="vaccines (Kenney et al., 2004; Chiu et al., 2007)."/>
  <result pre="needle has recently been designed for easier ID injection of" exact="influenza" post="vaccines (Laurent et al., 2007; Holland et al., 2008),"/>
  <result pre="approach has now been approved for ID delivery of seasonal" exact="influenza" post="vaccines. Moreover, microneedles are also under development for ID"/>
  <result pre="al., 2014). Recent studies have shown that ID delivery of" exact="influenza" post="vaccines using microneedles is superior to the conventional IM"/>
  <result pre="for inducing antibody responses to confer long lasting protection against" exact="influenza" post="virus infection in mice (Koutsonanos et al., 2012). We"/>
  <result pre="from lethal Ebola virus challenge in nonhuman primates immunized with" exact="rabies" post="virus based bivalent vaccine.PLoS Pathog.9:e1003389. 10.1371/journal.ppat.100338923737747 BosJ. D.KapsenbergM. L."/>
  <result pre="S.ChanK. H.WongW. H.LauY. L. (2007). Immunogenicity and safety of intradermal" exact="influenza" post="immunization at a reduced dose in healthy children.Pediatrics1191076–1082. 10.1542/peds.2006-317617545373"/>
  <result pre="M.QuanF. S.CompansR. W. (2014). Cutaneous immunization: an evolving paradigm in" exact="influenza" post="vaccines.Expert Opin. Drug Deliv.11615–627. 10.1517/17425247.2014.88594724521050 GrosethA.FeldmannH.StrongJ. E. (2007). The"/>
  <result pre="S.KuehneA. I.BarthJ. F.OrtizR. A.NicholsD. K.ZakS. E.et al. (2013). Venezuelan equine" exact="encephalitis" post="virus replicon particle vaccine protects nonhuman primates from intramuscular"/>
  <result pre="challenge with Ebolavirus.J. Virol.874952–4964. 10.1128/JVI.03361-1223408633 HollandD.BooyR.De LoozeF.EizenbergP.McDonaldJ.KarraschJ.et al. (2008). Intradermal" exact="influenza" post="vaccine administered using a new microinjection system produces superior"/>
  <result pre="R.VillarC. P.GlennG. M. (2004). Dose sparing with intradermal injection of" exact="influenza" post="vaccine.N. Engl. J. Med.3512295–2301. 10.1056/nejmoa04354015525714 KoutsonanosD. G.VassilievaE. V.StavropoulouA.ZarnitsynV. G.EsserE."/>
  <result pre="G.VassilievaE. V.StavropoulouA.ZarnitsynV. G.EsserE. S.TaherbhaiM. T.et al. (2012). Delivery of subunit" exact="influenza" post="vaccine to skin with microneedles improves immunogenicity and long-lived"/>
  <result pre="RegulesJ. A.BeigelJ. H.PaolinoK. M.VoellJ.CastellanoA. R.HuZ.et al. (2017). A recombinant vesicular" exact="stomatitis" post="virus Ebola vaccine.N. Engl. J. Med.376330–341. 10.1056/NEJMoa141421625830322 RendtorffR. C.WalkerL."/>
  <result pre="10.1056/NEJMoa141421625830322 RendtorffR. C.WalkerL. C.RowlandM. E.PackerH. (1959). Intradermal immunization against Asian" exact="influenza" post="in children.J. Am. Med. Assoc.170524–528.13653991 SeinoJ.EveleighP.WarnaarS.van HaarlemL. J.van EsL."/>
 </snippets>
</snippetsTree>
